Woman and Man | 18 years and more
- | Country :
- France
- | organs :
- Rein
- | Specialty :
- Thérapies Ciblées
- Chimiothérapie
Extract
Phase 2 open-label single-arm, multi-center study to evaluate the safety and efficacy of sunitinib malate in combination with AMG 386 as first line or second line therapy for subjects with metastatic renal cell carcinoma.
Scientific Abstract
en cours d'intégration;